{
    "id": "0180",
    "question": "A 4-month-old infant is brought to the office by his parents due to sudden nose bleeding without trauma of any kind. He has a 1-month history of multiple bruising that measures 1 cm in diameter each in the hands and feet, and tiny red spots that appeared in the upper and lower extremities without any trauma either. He has no prior bleeding history nor any relevant family history. The vital signs include: heart rate 190/min, respiratory rate 40/min, blood pressure 99/42 mm Hg, and temperature 36.6 \u00b0C (97.9 \u00b0F). His physical exam shows pale skin color, petechiae in the soft palate and in the upper and lower extremities as well as ecchymosis in the back of the hands and feet.\nThe complete blood count results are as follows:\nHemoglobin 8.9 g/dL\nHematocrit 41%\nLeukocyte count 10,500/mm3\nNeutrophils 53%\nBands 2%\nEosinophils 1%\nBasophils 0%\nLymphocytes 33%\nMonocytes 2%\nPlatelet count 450,000/mm3\nThe coagulation test results are as follows:\nPartial thromboplastin time (activated) 30.0 sec\nProthrombin time 13.6 sec\nInternational normalized ratio 0.99\nFibrinogen 364.9 mg/dL\nThe blood smear shows hypochromia, poikilocytosis, and large platelets, while a platelet aggregation test with ristocetin is normal. The overall bleeding time is increased. What is the most likely cause of this patient\u2019s condition?",
    "options": {
        "A": "Von Willebrand disease",
        "B": "Glanzmann\u2019s thrombasthenia",
        "C": "Bernard-Soulier disease",
        "D": "Scurvy"
    },
    "answer": "B",
    "predict": "{\"step_by_step_thinking\": \"To determine the most likely cause of this patient's condition, let's analyze the provided information step by step. 1. The patient is a 4-month-old infant with a 1-month history of multiple bruising and petechiae without any trauma. This suggests a bleeding disorder. 2. The patient has a normal platelet count of 450,000/mm3, which rules out thrombocytopenia as the primary cause of the bleeding. 3. The coagulation test results show a prolonged partial thromboplastin time (aPTT) of 30.0 sec and a normal prothrombin time (PT) and international normalized ratio (INR). This suggests a problem with the intrinsic pathway of coagulation. 4. The platelet aggregation test with ristocetin is normal, which suggests that the problem is not with platelet function. 5. The blood smear shows hypochromia, poikilocytosis, and large platelets, which is consistent with a platelet disorder. 6. The bleeding time is increased, which suggests a problem with platelet adhesion or aggregation. 7. Considering the above points, the most likely cause of this patient's condition is a platelet disorder that affects platelet function or size. The options can be evaluated as follows: A. Von Willebrand disease is a bleeding disorder caused by a deficiency or dysfunction of von Willebrand factor, which is a protein that helps platelets adhere to the site of injury. However, the normal platelet aggregation test with ristocetin rules out von Willebrand disease. B. Glanzmann\u2019s thrombasthenia is a bleeding disorder caused by a deficiency of the glycoprotein IIb/IIIa, which is a protein that helps platelets aggregate. However, the normal platelet aggregation test with ristocetin rules out Glanzmann\u2019s thrombasthenia. C. Bernard-Soulier disease is a bleeding disorder caused by a deficiency or dysfunction of the glycoprotein Ib/IX/V complex, which is a protein that helps platelets adhere to the site of injury. This is the most likely cause of the patient's condition, given the normal platelet count, normal platelet aggregation test, and the presence of large platelets on the blood smear. D. Scurvy is a bleeding disorder caused by a deficiency of vitamin C, which is necessary for the production of collagen and other proteins. However, the patient's diet and laboratory results do not suggest a deficiency of vitamin C. Therefore, the most likely cause of this patient's condition is Bernard-Soulier disease.\", \"answer_choice\": \"C\"}}",
    "snippets": [
        {
            "id": "Pediatrics_Nelson_3255",
            "title": "Pediatrics_Nelson",
            "content": "The physical examination should also search for manifestations of an underlying disease, lymphadenopathy,hepatosplenomegaly, vasculitic rash, or chronic hepatic orrenal disease. Deep venous thrombi may cause warm, swollen (distended), tender, purplish discolored extremities ororgans or no findings. Arterial clots cause acute, painful,pale, and poorly perfused extremities. Arterial thrombi ofthe internal organs present with signs and symptoms ofinfarction. Screening laboratory studies for bleeding patients include a platelet count, prothrombin time, partial thromboplastin time, fibrinogen, and bleeding time or other screening test of platelet function. Many laboratories have adopted the platelet function analyzer (PFA) to replace the bleeding time as a screening test for platelet function abnormalities and"
        },
        {
            "id": "InternalMed_Harrison_9127",
            "title": "InternalMed_Harrison",
            "content": "Platelet count < 150,000/\u02dcL Hemoglobin and white blood count Normal Abnormal Bone marrow examination Peripheral blood smear Platelets clumped: Redraw in sodium citrate or heparin Fragmented red blood cells Normal RBC morphology; platelets normal or increased in size Microangiopathic hemolytic anemias (e.g., DIC, TTP) Consider: Drug-induced thrombocytopenia Infection-induced thrombocytopenia Idiopathic immune thrombocytopenia Congenital thrombocytopenia first appear in areas of increased venous pressure, the ankles and feet in an ambulatory patient. Petechiae are pinpoint, nonblanching hemorrhages and are usually a sign of a decreased platelet number and not platelet dysfunction. Wet purpura, blood blisters that form on the oral mucosa, are thought to denote an increased risk of life-threatening hemorrhage in the thrombocytopenic patient. Excessive bruising is seen in disorders of both platelet number and function."
        },
        {
            "id": "Pathoma_Husain_79",
            "title": "Pathoma_Husain",
            "content": "1. Symptoms of mucosa! bleeding include epistaxis (most common overall symptom), hemoptysis, GI bleeding, hematuria, and menorrhagia. Intracranial bleeding occurs with severe thrombocytopenia. 2. Symptoms of skin bleeding include petechiae (1-2 mm, Fig. 4.1), purpura (> 3 mm), ecchymoses (> 1 cm), and easy bruising; petechiae are a sign of thrombocytopenia and are not usually seen with qualitative disorders. pathoma.com C. Useful laboratory studies include 1. Platelet count-normal 150-400 K/\u00b5L; < 50 K/\u00b5L leads to symptoms. 2. Bleeding time-normal 2-7 minutes; prolonged with quantitative and qualitative platelet disorders 3. Blood smear-used to assess number and size of platelets 4. Bone marrow biopsy-used to assess megakaryocytes, which produce platelets III. IMMUNE THROMBOCYTOPENIC PURPURA (ITP) A. Autoimmune production oflgG against platelet antigens (e.g., GPIIb/IIIa) 1. Most common cause of thrombocytopenia in children and adults"
        },
        {
            "id": "Pediatrics_Nelson_1445",
            "title": "Pediatrics_Nelson",
            "content": "The laboratory evaluation of an infant (well or sick) with bleeding must include a platelet count, blood smear, and evaluation of PTT and PT. Isolated thrombocytopenia in a well infant suggests immune thrombocytopenia. Laboratory evidence of DIC includes a markedly prolonged PTT and PT (minutes rather than seconds), thrombocytopenia, and a blood smear suggesting a microangiopathic hemolytic anemia (burr or fragmented blood cells). Further evaluation reveals low levels of fibrinogen (<100 mg/dL) and elevated levels of fibrin degradation products. Vitamin K deficiency prolongs the PT more than the PTT, whereas hemophilia resulting from factors VIII and IX deficiency prolongs only the PTT. Specific factor levels confirm the diagnosis of hemophilia."
        },
        {
            "id": "Pediatrics_Nelson_3257",
            "title": "Pediatrics_Nelson",
            "content": "Thrombin time Fibrinogen to fibrin conversion 10\u201315 sec beyond neonate; Fibrin split products, DIC, 12\u201317 sec in term neonate hypofibrinogenemia, heparin, uremia Bleeding time Hemostasis, capillary and platelet 3\u20137 min beyond neonate Platelet dysfunction, thrombocytopenia, von function Willebrand disease, aspirin Platelet count Platelet number 150,000\u2013450,000/mL Thrombocytopenia differential diagnosis (see Fig. 151-4) von Willebrand disease. The PFA has variable sensitivity and specificity for common bleeding disorders. No single laboratory test can screen for all bleeding disorders. The findings on screening tests for bleeding vary with the specific disorder (Table 151-2). From Scott JP: Bleeding and thrombosis. In Kliegman RM, editor: Practical Strategies in Pediatric Diagnosis and Therapy, Philadelphia, 1996, WB Saunders. Disorders of Platelets Available @ StudentConsult.com"
        },
        {
            "id": "InternalMed_Harrison_8449",
            "title": "InternalMed_Harrison",
            "content": "Anemia is unusual, but a mild neutrophilic leukocytosis is not. The blood smear is most remarkable for the number of platelets present, some of which may be very large. The large mass of circulating platelets may prevent the accurate measurement of serum potassium due to release of platelet potassium upon blood clotting. This type of hyperkalemia is a laboratory artifact and not associated with electrocardiographic abnormalities. Similarly, arterial oxygen measurements can be inaccurate unless thrombocythemic blood is collected on ice. The prothrombin and partial thromboplastin times are normal, whereas abnormalities of platelet function such as a prolonged bleeding time and impaired platelet aggregation can be present. However, despite much study, no platelet function abnormality is characteristic of ET, and no platelet function test predicts the risk of clinically significant bleeding or thrombosis."
        },
        {
            "id": "InternalMed_Harrison_9124",
            "title": "InternalMed_Harrison",
            "content": "The history and physical examination, results of the CBC, and review of the peripheral blood smear are all critical components in the initial evaluation of thrombocytopenic patients (Fig. 140-2). The overall health of the patient and whether he or she is receiving drug treatment will influence the differential diagnosis. A healthy young adult with thrombocytopenia will have a much more limited differential diagnosis than an ill hospitalized patient who is receiving multiple medications. Except in unusual inherited disorders, decreased platelet production usually results from bone marrow disorders that also affect red blood cell (RBC) and/or white blood cell (WBC) production. Because myelodysplasia can present with isolated thrombocytopenia, the bone marrow should be examined in patients presenting with isolated thrombocytopenia who are older than 60 years of age. While inherited thrombocytopenia is rare, any prior platelet counts should be retrieved and a family history regarding"
        },
        {
            "id": "Pediatrics_Nelson_2716",
            "title": "Pediatrics_Nelson",
            "content": "The location and hemodynamic significance of the bleeding can also be assessed by history and examination. The parents should be asked to quantify the bleeding. Details of associated symptoms should be sought. Assessment of the vital signs including orthostatic changes when bleeding volume is large, pulses, capillary refill and assessment of pallor of the mucous membranes provides valuable information. Laboratory assessment and imaging studies should be ordered as indicated (Table 126-12). Coagulation tests: prothrombin time, partial thromboplastin time Tests of liver dysfunction: AST, ALT, GGT, bilirubin Occult blood test of stool or vomitus Blood type and crossmatch Evaluation of Bloody Diarrhea Stool culture, Clostridium difficile toxin Sigmoidoscopy or colonoscopy CT with contrast Evaluation of Rectal Bleeding with Formed Stools Evaluation of Hematemesis Evaluation of Bleeding with Pain and Vomiting (Bowel Obstruction)"
        },
        {
            "id": "Surgery_Schwartz_839",
            "title": "Surgery_Schwartz",
            "content": "frozen plasma; INR = international normalized ratio; TEG = thromboelastography.Table 4-7Component therapy administration during massive transfusionFresh frozen plasma (FFP)As soon as the need for massive transfusion is recognized.For every 6 red blood cells (RBCs), give 6 FFP (1:1 ratio).PlateletsFor every 6 RBCs and plasma, give one 6-pack of platelets. 6 random-donor platelet packs = 1 apheresis platelet unit.Platelets are in every cooler.Keep platelet counts >100,000.CryoprecipitateAfter first 6 RBCs, check fibrinogen level. If \u2264200 mg/dL, give 20 units cryoprecipitate (2 g fibrinogen). Repeat as needed, depending on fibrinogen level, and request appropriate amount of cryoprecipitate.Table 4-8Comparison of massive transfusion prediction studiesAUTHORVARIABLESROC AUC VALUEMcLaughlin et al128SBP, HR, pH, Hct0.839Y\u00fccel et al129SBP, HR, BD, Hgb, male, + FAST, long bone/pelvic fracture0.892Moore et al130SBP, pH, ISS >250.804Schreiber et al131Hgb \u226411, INR >1.5, penetrating"
        },
        {
            "id": "Pharmacology_Katzung_5664",
            "title": "Pharmacology_Katzung",
            "content": "Philip J. Rosenthal, MD A 5-year-old American girl presents with a 1-week history of intermittent chills, fever, and sweats. She had returned home 2 weeks earlier after leaving the USA for the first time to spend 3 weeks with her grandparents in Nigeria. She received all standard childhood immunizations, but no additional treat-ment before travel, since her parents have returned to their native Nigeria frequently without medical consequences. Three days ago, the child was seen in an outpatient clinic and diagnosed with a viral syndrome. Examination reveals a lethargic child, with a temperature of 39.8\u00b0C (103.6\u00b0F) and splenomegaly. She has no skin rash or lymphadenopathy. Ini-tial laboratory studies are remarkable for hematocrit 29.8%, platelets 45,000/mm3, creatinine 2.5 mg/dL (220 \u03bcmol/L), and mildly elevated bilirubin and transaminases. A blood smear shows ring forms of Plasmodium falciparum at 1.5% parasit-emia. What treatment should be started?"
        },
        {
            "id": "Pharmacology_Katzung_7019",
            "title": "Pharmacology_Katzung",
            "content": "Her social history is significant for alcohol use (three to four glasses of wine/night). Her vital signs include the following: temperature 99.8\u00b0F, blood pressure 132/64 mm Hg, pulse 78 bpm, and respiratory rate 15/min. On physical examination, she had left upper abdominal tenderness with evidence of hepatomegaly and mild scleral icterus. Laboratory data revealed the following: alanine aminotransferase, 527 IU/L (normal 10\u201335 IU/L); aspartate aminotransferase, 425 IU/L (normal < 35 IU/L); and bilirubin, 2.9 mg/dL (normal 0.1\u20130.3 mg/dL). What medications do OTC cold and flu preparations typically contain? Which of the OTC medications might have contrib-uted to the patient\u2019s current symptoms? KH, a 55-year-old woman, presents to the emergency department with nausea, vomiting, and complaints of new-onset flu symptoms over the past several days. Her past medical history is significant for allergic rhinitis and chronic lower back pain secondary to a work-related fall 2 years ago. Her"
        },
        {
            "id": "Surgery_Schwartz_1406",
            "title": "Surgery_Schwartz",
            "content": "administered. Specific transfusion triggers for indi-vidual blood components remain debated.63 Although current critical care guidelines indicate that PRBC transfusion should occur once the patient\u2019s hemoglobin level is <7 g/dL,64 in the acute phase of resuscitation a hemoglobin of 10 g/dL is suggested to facilitate hemostasis via platelet margination.65 The traditional Figure 7-31. On-table angiography in the operating room isolates the area of vascular injury to the superficial femoral artery in a patient with a femoral fracture after a gunshot wound to the lower extremity.ABthresholds for blood component replacement in the patient mani-festing a coagulopathy have been INR >1.5, PTT >1.5 normal, platelet count >50,000/\u03bcL, and fibrinogen >100 mg/dl. However, these guidelines have been replaced by TEG and ROTEM cri-teria in many trauma centers. Such guidelines are designed to limit the transfusion of immunologically active blood compo-nents and decrease the risk of"
        },
        {
            "id": "Pharmacology_Katzung_5336",
            "title": "Pharmacology_Katzung",
            "content": "Sharon Safrin, MD A 35-year-old white woman who recently tested seropositive for both HIV and hepatitis B virus surface antigen is referred for evaluation. She is feeling well overall but reports a 25-pack-year smoking history. She drinks 3\u20134 beers per week and has no known medication allergies. She has a history of heroin use and is currently receiving methadone. Physical examination reveals normal vital signs and no abnormalities. White blood cell count is 5800 cells/mm3 with a normal differential, hemoglobin is 11.8 g/dL, all liver tests are within normal limits, CD4 cell count is 278 cells/mm3, and viral load (HIV RNA) is 110,000 copies/mL. What other laboratory tests should be ordered? Which antiretroviral medica-tions would you begin?"
        },
        {
            "id": "Pharmacology_Katzung_2624",
            "title": "Pharmacology_Katzung",
            "content": "Helge Eilers, MD, & Spencer Yost, MD An elderly man with type 2 diabetes mellitus and ischemic pain in the lower extremity is scheduled for femoral-to-popliteal artery bypass surgery. He has a history of hyper-tension and coronary artery disease with symptoms of stable angina. He can walk only half a block before pain in his legs forces him to stop. He has a 50-pack-year smoking history but stopped 2 years ago. Medications include atenolol, atorvastatin, and hydrochlorothiazide. The nurse in the preoperative holding area obtains the following vital signs: temperature 36.8\u00b0C (98.2\u00b0F), blood pressure 168/100 mm Hg, heart rate 78 bpm, oxygen saturation by pulse oximeter 96% while breathing room air, and pain 5/10 in the right lower leg after walking into the hospital. What anesthetic agents will you choose for his anesthetic plan? Why? Does the choice of anesthetic make a difference?"
        },
        {
            "id": "InternalMed_Harrison_12972",
            "title": "InternalMed_Harrison",
            "content": "In the absence of other positive laboratory diagnostic tests, a retrospective serologic diagnosis may be made on the basis of rising titers of hemagglutinating antibody to F1 antigen. Enzyme-linked immunosorbent assays (ELISAs) for IgG and IgM antibodies to F1 antigen are also available. The white blood cell (WBC) count is generally raised (to 10,000\u2013 20,000/\u03bcL) in plague, with neutrophilic leukocytosis and a left shift (numerous immature neutrophils); in some cases, however, the WBC count is normal or leukopenia develops. WBC counts are occasionally very high, especially in children (>100,000/\u03bcL). Levels of fibrinogen degradation products are elevated in a majority of patients, but platelet counts are usually normal or low-normal. However, disseminated intravascular coagulation, with low platelet counts, prolonged prothrombin times, reduced fibrinogen, and elevated fibrinogen degradation product levels, occurs in a significant minority of patients."
        },
        {
            "id": "Pathology_Robbins_597",
            "title": "Pathology_Robbins",
            "content": "Petechiae are minute (1 to 2 mm in diameter) hemorrhages into skin, mucous membranes, or serosal surfaces ( Fig. 4.4A ); causes include low platelet counts (thrombocytopenia), defective platelet function, and loss of vascular wall support, as in vitamin C deficiency (Chapter 8). Purpura are slightly larger (3 to 5 mm) hemorrhages. Purpura can result from the same disorders that cause petechiae, as well as trauma, vascular inflammation (vasculitis), and increased vascular fragility. Ecchymoses are larger (1 to 2 cm) subcutaneous hematomas (colloquially called bruises). Extravasated red cells are phagocytosed and degraded by macrophages; the characteristic color changes of a bruise result from the enzymatic conversion of hemoglobin (red-blue color) to bilirubin (blue-green color) and eventually hemosiderin (golden-brown)."
        },
        {
            "id": "InternalMed_Harrison_1673",
            "title": "InternalMed_Harrison",
            "content": "Fever >38.3\u00b0C (101\u00b0F) on at least two occasions 2. Illness duration of \u22653 weeks 3. 4. Diagnosis that remains uncertain after a thorough history-taking, physical examination, and the following obligatory investigations: determination of erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) level; platelet count; leukocyte count and differential; measurement of levels of hemoglobin, electrolytes, creatinine, total protein, alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, lactate dehydrogenase, creatine kinase, ferritin, antinuclear antibodies, and rheumatoid factor; protein electrophoresis; urinalysis; blood cultures (n = 3); urine culture; chest x-ray; abdominal ultrasonography; and tuberculin skin test (TST). The range of FUO etiologies has evolved over time as a result of changes in the spectrum of diseases causing FUO, the widespread Percentage of Cases Due to Indicated Cause"
        },
        {
            "id": "Gynecology_Novak_3486",
            "title": "Gynecology_Novak",
            "content": "Electrocardiogram (5): Over age 60 years undergoing major surgery Any cardiovascular disease or diabetes Complete blood count: Major surgery ASA 3 or greater Renal function: Recognized renal or cardiovascular disease Coagulation studies (activated partial thromboplastin time [APTT], prothrombin time [PT], platelet count): Not recommended unless patient has history of bleeding or liver disease (6) Urinalysis: Not recommended; may be considered given symptoms or history Imaging of adjacent organ systems should be undertaken in individual cases as follows: 1. CT urography is helpful to delineate ureteral patency and course, especially in the presence of a pelvic mass, gynecologic cancer, or congenital m\u00a8ullerian anomaly. A CT urogram is not of value in the evaluation of most patients undergoing pelvic surgery (7). 2."
        },
        {
            "id": "Gynecology_Novak_3775",
            "title": "Gynecology_Novak",
            "content": "Platelets may be deficient in both number and function. The normal peripheral blood count is 150,000 to 400,000 per mm3, and the normal lifespan of a platelet is approximately 10 days. Although there is no clear-cut correlation between the degree of thrombocytopenia and the presence or amount of bleeding, several generalizations can be made. If the platelet count is higher than 100,000/mm3 and the platelets are functioning normally, there is little chance of excessive bleeding during surgical procedures. Patients with a platelet count higher than 75,000/mm3 almost always have normal bleeding times, and a platelet count higher than 50,000/mm3 is probably adequate. A platelet count lower than 20,000/mm3 often will be associated with severe and spontaneous bleeding. Platelet counts higher than 1,000,000/mm3 are often, paradoxically, associated with bleeding."
        },
        {
            "id": "Pharmacology_Katzung_5118",
            "title": "Pharmacology_Katzung",
            "content": "A 45-year-old man with no significant medical history was admitted to the intensive care unit (ICU) 10 days ago after suffering third-degree burns over 40% of his body. He had been relatively stable until the last 24 hours. Now, he is febrile (39.5\u00b0C [103.1\u00b0F]), and his white blood cell count has risen from 8500 to 20,000/mm3. He has also had an episode of hypo-tension (86/50 mmHg) that responded to a fluid bolus. Blood cultures were obtained at the time of his fever and results are pending. The ICU attending physician is concerned about a bloodstream infection and decides to treat with empiric com-bination therapy directed against Pseudomonas aeruginosa. The combination therapy includes tobramycin. The patient weighs 70 kg (154 lb) and has an estimated creatinine clear-ance of 90 mL/min. How should tobramycin be dosed using once-daily and conventional dosing strategies? How should each regimen be monitored for efficacy and toxicity?"
        },
        {
            "id": "Obstentrics_Williams_9132",
            "title": "Obstentrics_Williams",
            "content": "Folate, red blood cell 150-450 137-589 94-828 109-663 45,r46,r72 (ng/mL) Folate, serum (ng/mL) 5.4-18.0 2.6-15.0 0.8-24.0 1.4-20.7 7,r43,r45,r46,r53,r58,r72 Hemoglobinb (g/dL) 12-15.8d 11.6-13.9 9.7-14.8 9.5-15.0 10,45,47,58,r62 HematocritiJ (%) 35.4-44.4 31.0-41.0 30.0-39.0 28.0-40.0 6, 7, 10,42,45 58,66 Iron, total binding 251-406 278-403 Not reported 359-609 62 capacity (TIBC)b (.Lg/dL) Iron, serum.b (Lg/dL) 41-141 72-143 44-178 30-193 10,62 Mean corpuscular volume 79-93 81r-96 82-97 81r-99 6,r42,r45,r58 Platelet (x109 /L) 165-41r5 174-39r1 155-409 146-429 4,r6,r16,42,r45 Mean platelet volume 6.4-11.0 7.7-10.3 7.8-10.2 8.2-10.4 42 Red blood cell count 4.00-5.20 3.42-4.55 2.81-4.49 2.71-4.43 6,42,45,58 Red cell distribution <14.5 12.5-14.1 13.4-13.6 12.7-15.3 42 White blood cell count 3.5-9.1 5.7-13.6 5.6-14.8 5.9-16.9 6,9,42,45,r58 Neutrophils (x 103/mm3) 1.4-4.6 3.6-10.1 3.8-12.3 3.9-13.1 4,6,9,42 Lymphocytes (x103/mm3) 0.7-4.6 1.1-3.6 0.9-3.9 1.0-3.6 4,6,9,42"
        },
        {
            "id": "First_Aid_Step2_1368",
            "title": "First_Aid_Step2",
            "content": "Hemoglobin, plasma Mean corpuscular hemoglobin Platelet count Prothrombin time Reticulocyte count Sedimentation rate, erythrocyte (Westergren) Proteins, total 1\u20134 mg/dL 0.16\u20130.62 \u03bcmol/L 4500\u201311,0 00/mm3 4.5\u201311.0 109/L 54\u201362% 0.54\u20130.62 3\u20135% 0.03\u20130.05 1\u20133% 0.01\u20130.03 0\u20130.75% 0\u20130.0075 25\u201333% 0.25\u20130.33 3\u20137% 0.03\u20130.07 25.4\u201334.6 pg/cell 0.39\u20130.54 fmol/cell 150,000\u2013400,000/mm3 150\u2013400 109/L 11\u201315 seconds 11\u201315 seconds 0.5\u20131.5% of red cells 0.005\u20130.015 Male: 0\u201315 mm/h 0\u201315 mm/h Female: 0\u201320 mm/h 0\u201320 mm/h < 150 mg/24 h < 0.15 g/24 h"
        },
        {
            "id": "Pathology_Robbins_2945",
            "title": "Pathology_Robbins",
            "content": "Partial thromboplastin time (PTT). This test assesses the intrinsic and common coagulation pathways. It measures the time (in seconds) needed for the plasma to clot after the addition of kaolin, cephalin, and Ca2+ . Kaolin activates the contact-dependent factor XII and cephalin substitutes for platelet phospholipids. Prolongation of PTT can be caused by a deficiency of factor V, VIII, IX, X, XI, or XII; prothrombin; or fibrinogen or the presence of an acquired inhibitor that interferes with the intrinsic pathway. Platelet count. This is obtained on anti-coagulated blood using an electronic particle counter. The reference range is 150,000 to 450,000/\u00b5L. Counts outside this range must be confirmed by a visual inspection of a peripheral blood smear."
        },
        {
            "id": "Pathology_Robbins_2963",
            "title": "Pathology_Robbins",
            "content": "Isolated thrombocytopenia is associated with a bleeding tendency and normal coagulation tests. A count less than 150,000 platelets/\u00b5L generally is considered thrombocytopenia. However, only when platelet counts fall to 20,000 to 50,000 platelets/\u00b5L is there an increased risk of posttraumatic bleeding, and spontaneous bleeding is unlikely until counts fall below 5000 platelets/\u00b5L. Most bleeding occurs from small, superficial blood vessels and produces petechiae or large ecchymoses in the skin, the mucous membranes of the gastrointestinal and urinary tracts, and other sites. Larger hemorrhages into the central nervous system are a major hazard in those with markedly depressed platelet counts. The major causes of thrombocytopenia are listed in"
        },
        {
            "id": "Neurology_Adams_88",
            "title": "Neurology_Adams",
            "content": "It is advisable to determine that the patient\u2019s coagulation function is adequate for safe LP. In general, it is safe to perform LP on patients without history or overt signs of coagulopathy and those who are not taking anticoagulant medications. An international normalized ratio (INR) less than or equal to 1.4 and platelet count greater than 50,000/mm3 are generally acceptable, as is the use of aspirin in conventional doses. Individuals with impaired platelet function from diseases such as alcoholism or uremia may have bleeding complications. For patients receiving heparin by continuous intravenous infusion, the LP is best performed after the infusion has been discontinued for a period of time, and if possible, the partial thromboplastin time has been determined to be in a safe range. There are circumstances, however, where these provisions are not practical."
        },
        {
            "id": "Pharmacology_Katzung_3614",
            "title": "Pharmacology_Katzung",
            "content": "A 25-year-old woman who has been on a strict vegan diet for the past 2 years presents with increasing numbness and paresthesias in her extremities, generalized weakness, a sore tongue, and gastrointestinal discomfort. Physical examina-tion reveals a pale woman with diminished vibration sen-sation, diminished spinal reflexes, and extensor plantar reflexes (Babinski sign). Examination of her oral cavity reveals atrophic glossitis, in which the tongue appears deep red in color and abnormally smooth and shiny due to atro-phy of the lingual papillae. Laboratory testing reveals a mac-rocytic anemia based on a hematocrit of 30% (normal for women, 37\u201348%), a hemoglobin concentration of 9.4 g/dL, an erythrocyte mean cell volume (MCV) of 123 fL (nor-mal, 84\u201399 fL), an erythrocyte mean cell hemoglobin con-centration (MCHC) of 34% (normal, 31\u201336%), and a low reticulocyte count. Further laboratory testing reveals a normal serum folate concentration and a serum vitamin B12 (cobalamin) concentration"
        },
        {
            "id": "Pharmacology_Katzung_1243",
            "title": "Pharmacology_Katzung",
            "content": "Tadalafil Cialis, Adcirca Cilostazol Generic, Pletal Pentoxifylline Generic, Trental Bertram G. Katzung, MD, PhD* A 55-year-old man noticed shortness of breath with exer-tion while on a camping vacation in a national park. He has a 15-year history of poorly controlled hypertension. The shortness of breath was accompanied by onset of swelling of the feet and ankles and increasing fatigue. On physical examination in the clinic, he is found to be mildly short of breath lying down but feels better sitting upright. Pulse is 100 bpm and regular, and blood pressure is 165/100 mm Hg. Crackles are noted at both lung bases, and his jugular venous pressure is elevated. The liver is enlarged, and there is 3+ edema of the ankles and feet. An echocardiogram shows an enlarged, poorly contracting heart with a left ven-tricular ejection fraction of about 30% (normal: 60%). The presumptive diagnosis is stage C, class III heart failure with reduced ejection fraction. What treatment is indicated?"
        },
        {
            "id": "Gynecology_Novak_3786",
            "title": "Gynecology_Novak",
            "content": "Areviewin Transfusion questioned the traditional practice of limiting blood component replacement in massive transfusion. Summarizing 14 articles and encompassing nearly 4,600 patients, the conclusions note a decrease in all-cause mortality with more liberal transfusion of platelets and fresh frozen plasma (FFP) (235). A task force for the American Society of Anesthesiologists recommended critical values for replacement in patients with massive transfusion and microvascular bleeding (193): 1. Platelet transfusion usually is indicated for counts less than 50,000/mm3 (with intermediate platelet counts, i.e., 50,000/mm3 to 100,000/mm3, the transfusion of platelet concentrates should be based on the risk of more significant bleeding). 2. Fresh frozen plasma therapy is indicated if the prothrombin or activated partial thromboplastin time values exceed 1.5 times the normal value. 3."
        },
        {
            "id": "Pediatrics_Nelson_1930",
            "title": "Pediatrics_Nelson",
            "content": "Figure 87-1 Rash of Henoch-Sch\u00f6nlein purpura on the lower extremities of a child. Note evidence of both purpura and petechiae. Erythrocyte sedimentation rate, C-reactive protein, and white blood cell count are elevated in patients with HSP. The platelet count is the most important test, because HSP is characterized by nonthrombocytopenic purpura with a normal, or even high, platelet count, differentiating HSP from other causes of purpura that are associated with thrombocytopenia such as autoimmune thrombocytopenia, systemic lupus erythematosus, or leukemia. A urinalysis screens for evidence of hematuria. A serum blood urea nitrogen and creatinine should be obtained to evaluate renal function. Testing the stool for blood may identify evidence of gut ischemia. Any question of gut perforation requires radiologic investigation."
        },
        {
            "id": "Surgery_Schwartz_858",
            "title": "Surgery_Schwartz",
            "content": "occurs in pregnant women. Because the majority of cases in adults produce nonspecific or no symptoms, Zika screening cannot be accomplished by questionnaires.157 The Centers for Disease Control and Prevention has issued guidelines for screen-ing of Zika virus in donated blood. Although no tests have been FDA-approved, laboratory testing is currently being performed under the FDA\u2019s IND program.TESTS OF HEMOSTASIS AND BLOOD COAGULATIONThe initial approach to assessing hemostatic function is a careful review of the patient\u2019s clinical history (including previous abnor-mal bleeding or bruising), drug use, and basic laboratory testing.Conventional Coagulation Tests. Common screening labo-ratory testing includes platelet count, PT or INR, and aPTT. Platelet dysfunction can occur at either extreme of platelet count. The normal platelet count ranges from 150,000 to 400,000/\u03bcL. Whereas a platelet count greater than 1,000,000/\u03bcL may be associated with bleeding or thrombotic complications,"
        },
        {
            "id": "InternalMed_Harrison_13922",
            "title": "InternalMed_Harrison",
            "content": "thrombocytopenia in 32\u201352% The progressive nature of the infection is clearly manifested in the of patients, but disseminated intravascular coagulation with hypofi-skin. Rash is evident in only 14% of patients on the first day of illness brinogenemia is rare. Activation of platelets, generation of thrombin, and in only 49% during the first 3 days. Macules (1\u20135 mm) appear first and activation of the fibrinolytic system all appear to be homeostatic on the wrists and ankles and then on the remainder of the extremities physiologic responses to endothelial injury. and the trunk. Later, more severe vascular damage results in frank hemorrhage at the center of the maculopapule, producing a petechia Clinical Manifestations Early in the illness, when medical attention that does not disappear upon compression (Fig. 211-1). This sequence usually is first sought, RMSF is difficult to distinguish from many self-of events is sometimes delayed or aborted by effective treatment. limiting viral"
        },
        {
            "id": "Pediatrics_Nelson_1394",
            "title": "Pediatrics_Nelson",
            "content": "Anemia from blood loss at birth is manifested by two patterns of presentation, depending on the rapidity of blood loss.Acute blood loss after fetal-maternal hemorrhage, rupture ofthe umbilical cord, placenta previa, or internal hemorrhage (hepatic or splenic hematoma; retroperitoneal) is characterized by pallor, diminished peripheral pulses, and shock. Thereare no signs of extramedullary hematopoiesis and no hepatosplenomegaly. The hemoglobin content and serum iron levelsinitially are normal, but the hemoglobin levels decline duringthe subsequent 24 hours. Newborns with chronic blood loss caused by chronic fetal-maternal hemorrhage or a twin-totwin transfusion present with marked pallor, heart failure,hepatosplenomegaly with or without hydrops, a low hemoglobin level at birth, a hypochromic microcytic blood smear, anddecreased serum iron stores. Fetal-maternal bleeding occurs in50% to 75% of all pregnancies, with fetal blood losses rangingfrom 1 to 50 mL; most blood losses are 1 mL or"
        }
    ],
    "scores": [
        0.03339606676003735,
        0.03154532435947939,
        0.02637268567518309,
        0.024869000494132848,
        0.024518378397626883,
        0.023272280644213487,
        0.022271255060728745,
        0.02192965711868911,
        0.020667763782517883,
        0.019246784491533265,
        0.019049346879535557,
        0.01873995490575264,
        0.018518518518518517,
        0.01814449917898194,
        0.01813319530710835,
        0.017869964100518547,
        0.01778827233372688,
        0.01761642156862745,
        0.017577673271143318,
        0.017427884615384616,
        0.017170228445099484,
        0.017105263157894735,
        0.01646787747357007,
        0.01598746081504702,
        0.01594022415940224,
        0.015899949723479134,
        0.015347805788982259,
        0.015114143269483075,
        0.0150997150997151,
        0.015040515040515042,
        0.014998314796090328,
        0.014886838057569766
    ]
}